SonoThera Closes Oversubscribed $125 Million Series B Financing to Advance Clinical Development of Ultrasound-Mediated Nonviral Genetic Medicines. Learn more.
SonoThera featured in the Wall Street Journal’s Future of Everything story on using ultrasound and microbubbles to enable therapeutic delivery to challenging organs